NL-OMON42143已完成不适用
PILOT-STUDY FOR PROFILING PSA GLYCOSYLATION AS PUTATIVE PROSTATE CANCER BIOMARKER BY HIGH RESOLUTION NATIVE MASS SPECTROMETRY - Profiling PSA glycosylation
niversitair Medisch Centrum Utrecht0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Inclusion criteria for patients:
- •-Male gender
- •-Signed written informed consent
- •-Biopsy-proven prostate cancer, eligible for surgery
- •-Age 55 - 70 years
- •-Willing and able to collect semen;Inclusion criteria for controls:
- •-Male gender
- •-Visiting the outpatient clinic because of lower urinary tract symptoms (LUTS)
- •-Signed written informed consent
- •-Serum PSA < 3.0 ng/ml
- •-No suspicion for prostate cancer on digital rectal examination and transrectal ultrasound as judged by the urologist
- •-Willing and able to collect semen
排除标准
- •-Urinary tract infection
研究者
相似试验
已完成
不适用
Clinical trial to investigate the extent of P-glycoprotein inhibition after oral administration of HM30181A in healthy male subjects: An open, single sequence, 4-period crossover within dose group, parallel dose group desigKCT0000983Hanmi Pharm18
进行中（未招募）
1 期
Is P-glycoprotein activity decreased in Alzheimer's disease? A pilot study.EUCTR2013-001724-19-ATMedizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie
招募中
不适用
PSA Glycomics Assay for Early Detection of Prostate CancerPSAProstate CancerNCT04393376Prof.dr. H.P. Beerlage150
进行中（未招募）
不适用
Pilot study to assess the difference in glycemic profiles between vildagliptin and glimepiride using CGM deviceEUCTR2010-021236-34-DEovartis Pharma Services AG
尚未招募
不适用
Advanced Glycation End Products in Patients with Peripheral Arterial Occlusive Disease or Abdominal Aortic AneurysmPatients with an abdominal aortic aneurysm (AAA) or peripheral arterial occlusive disease (PAOD) with and without diabetes mellitus.NL-OMON29072niversity Medical Center Groningen120